Your shopping cart is currently empty

NF-κB-IN-18 (Compound 5k) is an orally active NF-κB inhibitor that suppresses the phosphorylation of p65 and demonstrates significant anti-inflammatory activity in mice with xylene-induced ear edema.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | NF-κB-IN-18 (Compound 5k) is an orally active NF-κB inhibitor that suppresses the phosphorylation of p65 and demonstrates significant anti-inflammatory activity in mice with xylene-induced ear edema. |
| In vitro | NF-κB-IN-18 (at concentrations of 10-100 μM over 12 hours) inhibits LPS-induced p65 phosphorylation in RAW264.7 cells [1]. |
| In vivo | NF-κB-IN-18 (25-100 mg/kg, administered intraperitoneally and orally) demonstrates potent anti-inflammatory activity in the xylene-induced mouse ear edema test, with an 81.77% inhibition rate following intraperitoneal administration [1]. |
| Molecular Weight | 500.542 |
| Formula | C29H28N2O6 |
| Smiles | CC1(C=CC2=C3C(=C(C(=C2O1)C(=O)OC)OCC(=O)NC4=CC5=C(C=C4)N=CC=C5)C=CC(O3)(C)C)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.